Glatiramer acetate reduces the risk for experimental cerebral malaria: a pilot study
-
* Corresponding author: Peter Lackner peter.lackner@i-med.ac.at
Malaria Journal 2009, 8:36 doi:10.1186/1475-2875-8-36
Accesses
- Last 30 days: 50 accesses
- Last 365 days: 453 accesses
- All time: 2342 accesses